Senomyx Chairman, CSO Steps Down, New Appointments Made | GenomeWeb

NEW YORK, May 22 – Senomyx said Tuesday that it had appointed Paul Grayson chairman of the board and promoted Mark Zoller to the position of chief scientific officer, continuing a management reshuffle that has taken place over the past month.

Grayson, who is CEO of the company, and Zoller, who is vice president of research, will be replacing Lubert Stryer in his roles as chairman and CSO.

Stryer is returning to Stanford University following a two-year sabbatical at Senomyx.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.